Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.40
+8.7%
$0.48
$0.19
$1.01
$10.02M1.2136,810 shs1,086 shs
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$0.25
-2.7%
$0.21
$0.12
$3.67
$12.21M0.03876,116 shs1.08 million shs
IVF
INVO Fertility
$0.92
-11.8%
$0.00
$0.90
$17.04
$2.25M2.23547,852 shs355,699 shs
WOK
WORK Medical Technology Group
$0.71
+0.2%
$0.65
$0.36
$8.45
$10.41MN/A1.08 million shs124,639 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
+8.68%-3.11%-19.58%-3.53%-53.78%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-2.71%+13.57%-1.41%+0.40%-91.19%
IVF
INVO Fertility
-11.75%-24.77%-46.95%+91,779,900.00%+91,779,900.00%
WOK
WORK Medical Technology Group
-4.18%-0.79%-10.63%+42.96%+71,479,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
1.2487 of 5 stars
0.05.00.00.02.71.70.0
IVF
INVO Fertility
N/AN/AN/AN/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00
N/AN/AN/A
IVF
INVO Fertility
0.00
N/AN/AN/A
WOK
WORK Medical Technology Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M0.83N/AN/A($1.30) per share-0.31
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$64.47M0.18N/AN/A($0.80) per share-0.31
IVF
INVO Fertility
$6.53M0.30N/AN/A($29.86) per share-0.03
WOK
WORK Medical Technology Group
$11.51M0.91N/AN/A$1.10 per share0.65
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$1.08N/AN/A-80.42%N/A-188.47%8/18/2025 (Estimated)
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-$8.44M-$0.30N/AN/A-13.59%N/A-25.97%N/A
IVF
INVO Fertility
-$9.10M-$34.06N/AN/A-377.73%N/A-88.18%N/A
WOK
WORK Medical Technology Group
-$3.49MN/A0.00N/AN/AN/AN/AN/A

Latest IVF, WOK, BTCY, and DHAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
IVF
INVO Fertility
N/A-$12.53N/A-$12.53N/A$1.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/A
IVF
INVO Fertility
N/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A
0.51
0.34
IVF
INVO Fertility
N/A
0.08
0.07
WOK
WORK Medical Technology Group
N/A
1.03
0.87

Institutional Ownership

CompanyInstitutional Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
27.76%
IVF
INVO Fertility
12.02%
WOK
WORK Medical Technology Group
N/A

Insider Ownership

CompanyInsider Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
49.58%
IVF
INVO Fertility
0.57%
WOK
WORK Medical Technology Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A47.34 million23.87 millionN/A
IVF
INVO Fertility
102.16 million2.15 millionN/A
WOK
WORK Medical Technology Group
22614.59 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.40 +0.03 (+8.68%)
As of 06/27/2025 02:53 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

DIH Holding US stock logo

DIH Holding US NASDAQ:DHAI

$0.25 -0.01 (-2.71%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$0.25 +0.00 (+0.80%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

INVO Fertility NASDAQ:IVF

$0.92 -0.12 (-11.75%)
As of 06/27/2025 04:00 PM Eastern

NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).

WORK Medical Technology Group NASDAQ:WOK

$0.71 +0.00 (+0.20%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$0.72 +0.00 (+0.03%)
As of 06/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.